NVSEF Stock: Novartis AG Stock Price, Analysis & Insights
Get live NVSEF stock price $144.88, comprehensive Novartis AG stock analysis, charts, news, and expert forecast. Real-time NVSEF stock data and investment insights.
Loading chart data...
Novartis AG (NVSEF) Overview
Novartis AG (NVSEF) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - General industry . As of the latest trading session, NVSEF trades at $144.88 with a market capitalization of 276.44B . Over the past 52 weeks, NVSEF has traded between $110.74 and $171.29 , with the current price positioned at approximately 56% of this range . The stock curre...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - General)
- Market cap: 276.44B
- Current price: $144.88
- 52-week range: $110.74 - $171.29
- P/E ratio: 20.76
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Novartis AG, a global pharmaceutical enterprise established in 1996 and based in Basel, Switzerland, is engaged in the entire lifecycle of healthcare products, from research and development to manufacturing and worldwide commercialization. The compan...
Company Information
- CEO
- Vasant Narasimhan
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 75883
Contact Information
- Website
- https://www.novartis.com
- Address
- Lichtstrasse 35
- Country
- CH
Investment Analysis & Business Insights
Investment Highlights
✓ Market leader with 276.4 billion market capitalization
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 20.8)
✓ Lower volatility stock (Beta: 0.49) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Novartis AG shareholders
- ⚠Market volatility can significantly impact stock price, especially for large-cap equities
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Novartis AG
- ⚠Investors should consider how Novartis AG fits within their overall portfolio allocation
Market Cap
276.44B
P/E Ratio (TTM)
20.76
Beta
0.49
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare NVSEF with peer companies:
- Price
- $189.90+0.00% (1D)
- Market cap
- 294.40B
- Price
- $46.74+1.89% (1D)
- Market cap
- 76.91B
- Price
- $10.93+0.92% (1D)
- Market cap
- 98.50B
- Price
- $25.12+1.84% (1D)
- Market cap
- 100.73B
- Price
- $43.34+3.94% (1D)
- Market cap
- 192.55B
- Price
- $414.00+1.22% (1D)
- Market cap
- 329.54B
- Price
- $50.42+0.56% (1D)
- Market cap
- 324.75B
- Price
- $411.25+0.00% (1D)
- Market cap
- 327.35B
- Price
- $86.67+0.00% (1D)
- Market cap
- 104.19B
- Price
- $20.58+1.81% (1D)
- Market cap
- 200.20B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
60/100 ⭐⭐⭐⭐
- Overall
- -1.4%
- NYSE
- -0.6%
- NASDAQ
- -2.2%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +0.2% | +1.6% | +1.7% | 19.1 | 100/100⭐⭐⭐⭐⭐ |
| Communication Services | -0.2% | -1.8% | +1.2% | 21.9 | 83/100⭐⭐⭐⭐⭐ |
| Energy | -0.2% | -6.1% | +1.5% | 37.0 | 75/100⭐⭐⭐⭐⭐ |
| Healthcare | -1.4% | -3.7% | -0.5% | 30.2 | 60/100⭐⭐⭐⭐ |
| Technology | -0.8% | -7.7% | +0.0% | 48.7 | 55/100⭐⭐⭐⭐ |
| Consumer Defensive | +0.7% | +3.0% | -1.6% | 31.1 | 50/100⭐⭐⭐ |
| Real Estate | -1.0% | -1.8% | -1.9% | 50.3 | 31/100⭐⭐ |
| Industrials | -2.7% | -7.6% | -2.1% | 41.5 | 30/100⭐⭐ |
| Basic Materials | -1.9% | -6.0% | -3.5% | 26.6 | 28/100⭐⭐ |
| Utilities | -2.1% | -6.9% | -8.5% | 25.3 | 24/100⭐ |
| Consumer Cyclical | -1.5% | -4.5% | -3.4% | 52.2 | 14/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score: 70% 1M momentum percentile + 30% valuation percentile (lower P/E ranks higher), shown as 0–100 with stars. Data as of 2026-06-11.